These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 27007621)

  • 41. Sustained delivery of siRNA/PEI complex from in situ forming hydrogels potently inhibits the proliferation of gastric cancer.
    Peng H; Yang H; Song L; Zhou Z; Sun J; Du Y; Lu K; Li T; Yin A; Xu J; Wei S
    J Exp Clin Cancer Res; 2016 Mar; 35():57. PubMed ID: 27029190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
    Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
    Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
    Park K; Lee MY; Kim KS; Hahn SK
    Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo.
    Xia W; Wang P; Lin C; Li Z; Gao X; Wang G; Zhao X
    J Control Release; 2012 Feb; 157(3):427-36. PubMed ID: 22036880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
    Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
    Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids.
    Wen J; Qiu N; Zhu Z; Bai P; Hu M; Qi W; Liu Y; Wei A; Chen L
    Drug Deliv; 2021 Dec; 28(1):1055-1066. PubMed ID: 34078185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications.
    Buchman YK; Lellouche E; Zigdon S; Bechor M; Michaeli S; Lellouche JP
    Bioconjug Chem; 2013 Dec; 24(12):2076-87. PubMed ID: 24180511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenylboronic acid-functionalized polyamidoamine-mediated Bcl-2 siRNA delivery for inhibiting the cell proliferation.
    Wu D; Yang J; Xing Z; Han H; Wang T; Zhang A; Yang Y; Li Q
    Colloids Surf B Biointerfaces; 2016 Oct; 146():318-25. PubMed ID: 27371891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery.
    Veiseh O; Kievit FM; Fang C; Mu N; Jana S; Leung MC; Mok H; Ellenbogen RG; Park JO; Zhang M
    Biomaterials; 2010 Nov; 31(31):8032-42. PubMed ID: 20673683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by a mTOR siRNA-loaded cyclodextrin nanovector.
    Liu X; Wang G; You Z; Qian P; Chen H; Dou Y; Wei Z; Chen Y; Mao C; Zhang J
    Biomaterials; 2014 May; 35(14):4401-16. PubMed ID: 24582377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo.
    Chen Y; Lian G; Liao C; Wang W; Zeng L; Qian C; Huang K; Shuai X
    J Gastroenterol; 2013 Jul; 48(7):809-21. PubMed ID: 23179610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biscarbamate cross-linked low molecular weight Polyethylenimine polycation as an efficient intra-cellular delivery cargo for cancer therapy.
    Ge X; Feng J; Chen S; Zhang C; Ouyang Y; Liu Z; Yuan W
    J Nanobiotechnology; 2014 Apr; 12():13. PubMed ID: 24708586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
    Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
    Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Facial amphipathic deoxycholic acid-modified polyethyleneimine for efficient MMP-2 siRNA delivery in vascular smooth muscle cells.
    Kim D; Lee D; Jang YL; Chae SY; Choi D; Jeong JH; Kim SH
    Eur J Pharm Biopharm; 2012 May; 81(1):14-23. PubMed ID: 22311297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tyrosine-modified PEI: a novel and highly efficient vector for siRNA delivery in mammalian cells.
    Creusat G; Zuber G
    Nucleic Acids Symp Ser (Oxf); 2008; (52):91-2. PubMed ID: 18776268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery.
    Lee Y; Lee SH; Kim JS; Maruyama A; Chen X; Park TG
    J Control Release; 2011 Oct; 155(1):3-10. PubMed ID: 20869409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Self-assembly cationic nanoparticles based on cholesterol-grafted bioreducible poly(amidoamine) for siRNA delivery.
    Chen CJ; Wang JC; Zhao EY; Gao LY; Feng Q; Liu XY; Zhao ZX; Ma XF; Hou WJ; Zhang LR; Lu WL; Zhang Q
    Biomaterials; 2013 Jul; 34(21):5303-16. PubMed ID: 23570718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
    Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
    Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells.
    Mok H; Veiseh O; Fang C; Kievit FM; Wang FY; Park JO; Zhang M
    Mol Pharm; 2010 Dec; 7(6):1930-9. PubMed ID: 20722417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.